Cardinal Health expands network of radiopharmaceutical manufacturing and distribution
Will manage ProVision's cyclotron in Tennessee
The Nuclear Pharmacy Business of Cardinal operates the largest network of “radiopharmacies” and production capacity in the US, with roughly 100 pharmacies compounding and dispensing molecular imaging biomarkers that are used in clinical research and diagnosis and care for patients suffering cancer, neurological disorders and heart disease. (Cardinal has an additional 60 pharmacies that only dispense the agents.) Now, in an agreement with ProVision Healthcare, the company will manage ProVision’s cyclotron in Knoxville, TN.
A cyclotron, which is itself used in therapy, can produce imaging agents for a technique called positron emission tomography (PET). Cardinal pharmacies compound, package and dispense patient-specific PET agents with radiopharmaceuticals produced by the cyclotron.
ProVision’s cyclotron is part of the East Tennessee Health Center, which includes diagnostic imaging, breast care and wellness, oncology and cardiology services. Cardinal will also make the facility available to support the development of new PET imaging agents.
